Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 10:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1273–1296 of 13,937 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Substance Withdrawal Syndrome
Interventions: Melatonin, Matched Placebo; Dietary Supplement
Lead sponsor: Duquesne University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Spasticity
Interventions: Phase 2; Low Dose MYOBLOC (15,000 Units), Phase 2; High Dose MYOBLOC (20,000 Units), Phase 2; Placebo, Phase 3; MYOBLOC, Phase 3; Placebo; Drug
Lead sponsor: Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 4
States / cities: Downey, California • Boise, Idaho • Port Royal, South Carolina + 1 more

Conditions: Spinal Cord Injuries
Interventions: Brivaracetam, Placebo; Drug · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Englewood, Colorado • Minneapolis, Minnesota

Conditions: Sexual Dysfunctions, Psychological
Interventions: Flibanserin, Placebo; Drug
Lead sponsor: Sprout Pharmaceuticals, Inc; Industry
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 1,090 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 75
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 61 more

Conditions: Preterm Birth
Interventions: PreTRM test; Diagnostic Test
Lead sponsor: Ware Branch; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,208 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 4
States / cities: Murray, Utah • Ogden, Utah • Provo, Utah + 1 more

Conditions: Postdural Puncture Headache, Post-Lumbar Puncture Headache, Cerebrospinal Fluid Leaks
Interventions: Morphine, Saline; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Immunization, Reminder Systems
Interventions: Parent Only Phone Call, Parent and Adolescent Phone Call; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 13 Years to 17 Years · Female only
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Iron-deficiency, Iron Deficiency Anemia, Iron Deficiency Anemia Treatment
Interventions: Iron supplement with a lunch meal containing beef, Iron supplement with a lunch meal containing plant-based alternative; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Relapsed Small Cell Lung Cancer
Interventions: Irinotecan, Lurbinectedin, Topotecan; Drug
Lead sponsor: PharmaMar; Industry
Eligibility: 18 Years and older
Enrollment: 705 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 15
States / cities: Chandler, Arizona • Hot Springs, Arkansas • Fort Myers, Florida + 12 more

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: L-carnosine (dietary supplement); Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 65 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 4
States / cities: Bridgeville, Pennsylvania • DuBois, Pennsylvania • McKeesport, Pennsylvania + 1 more

Conditions: Heart Failure With Preserved Ejection Fraction
Interventions: m-health cardiac rehabilitation; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Nicotine Dependence
Interventions: mSMART; Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Dementia, Social Behavior, Caregiver Burden
Interventions: Hasbro Joy for All robot pet companion; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Carcinomas, Squamous Cell, Dysphagia
Interventions: Acupuncture; Device
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Knee Osteoarthritis
Interventions: Regenexx SD, Exercise Therapy; Procedure · Behavioral
Lead sponsor: Regenexx, LLC; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Des Plaines, Illinois

Conditions: Cerebral Palsy, Motor Deficits
Interventions: Pediatric Constraint-Induced Movement therapy, Conventional pediatric motor rehabilitation therapy; Behavioral
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 2 Years to 6 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Acne Rosacea
Interventions: doxycycline hyclate 20 mg twice daily; Drug
Lead sponsor: CollaGenex Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2002
U.S. locations: 7
States / cities: Gainesville, Florida • Miami, Florida • West Palm Beach, Florida + 4 more

Conditions: Non-Small Cell Lung Cancer
Interventions: bevacizumab, erlotinib HCl, placebo; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 636 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2019
U.S. locations: 4
States / cities: Vallejo, California • Athens, Georgia • Kansas City, Kansas + 1 more

Conditions: Dysautonomia, Familial, Baroreflex Failure Syndrome
Interventions: Carbidopa Low-Dose, Placebo, Carbidopa High-Dose; Drug · Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 10 Years to 60 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: New York, New York

Conditions: Epilepsy
Interventions: Memory Tasks, Attention/arousal tasks, Language tasks, Visuospatial tasks, Auditory Tasks, Brain Stimulation, Social Emotional Task, Recording of facial expressions, Judgement/Impulsivity Task; Other · Procedure
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 175 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2032
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Scoliosis
Interventions: Not listed
Lead sponsor: Mazor Robotics; Industry
Eligibility: 10 Years to 21 Years
Enrollment: 272 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 4
States / cities: San Diego, California • Orlando, Florida • Atlanta, Georgia + 1 more

Conditions: Morbid Obesity
Interventions: Standard-LAGB, Plicated-LAGB; Device
Lead sponsor: Dana Portenier, MD; Other
Eligibility: 18 Years to 60 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Preterm Birth
Interventions: Docosahexaenoic acid - 800mg/day, Docosahexaenoic acid - 200mg/day, Placebo; Drug · Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 3
States / cities: Kansas City, Kansas • Cincinnati, Ohio • Columbus, Ohio

Conditions: HIV Infections
Interventions: BMS-955176, Atazanavir (ATV), Ritonavir (RTV), Dolutegravir (DTG), Tenofovir (TDF); Drug
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 16
States / cities: Beverly Hills, California • Los Angeles, California • Palm Springs, California + 13 more

Search by objective public record fields.

The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity

Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord Injury

Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder

Prediction and Prevention of Preterm Birth (PREVENT-PTB Study)

Incidence of Headache Following an Unintentional Dural Puncture

Study of Adolescent Immunization Recall Systems

Meals to Improve Absorption of Iron Supplements

Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)

L-carnosine for Schizophrenia

Efficacy of an m-Health Cardiac Rehabilitation Program in Heart Failure With Preserved Ejection Fraction

Stage Ib Trial of mSMART for Smoking Cessation Medication Adherence

Companion Robotic Pets and Older Adults

A Pilot Study of Acupuncture Treatment for Dysphagia

Regenexx™ SD Versus Exercise Therapy for Treatment of Knee Osteoarthritis With Historical Comparison to TKA

Constraint-Based Therapy to Improve Motor Function in Children With Cerebral Palsy

Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea

A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung Cancer

Carbidopa for the Treatment of Excessive Blood Pressure Variability

Human Intracranial Electrophysiology

Robotic vs. Freehand Corrective Surgery for Pediatric Scoliosis

Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding

Assessment of DHA On Reducing Early Preterm Birth

Strategy-confirming Study of BMS-955176 to Treat HIV-1 Infected Treatment-experienced Adults